プレシジョン・カーディオロジー市場：オファリング、サンプル、テクノロジー、適応症、エンドユーザー別-2025-2030年の世界予測

プレシジョン・カーディオロジー市場は、2023年に138億4,000万米ドルと評価され、2024年には156億7,000万米ドルに達すると予測され、CAGR 12.04%で成長し、2030年には306億8,000万米ドルに達すると予測されています。

プレシジョン・カーディオロジーは、患者の遺伝的要因、表現型要因、生活習慣要因をプロファイリングし、的を絞った治療を行うことで、心血管疾患（CVD）をオーダーメイドで管理することに焦点を当てています。プレシジョン・カーディオロジーの必要性は、世界の死亡原因の第一位であるCVDの世界の負担の増加から生じており、より個別化された効果的な治療戦略が必要とされています。用途はリスク評価、診断、治療モニタリング、投薬の個別化など多岐にわたり、臨床現場、研究機関、医療機関、バイオ製薬企業において最終用途の大きな可能性を提供しています。市場成長の主な原動力は、ゲノミクスとバイオテクノロジーの進歩、個別化医療の採用拡大、臨床医と患者の間での精密医療の利点に対する意識の高まりです。主な成長要因としては、ゲノミクスに関する政府の取り組み、ヘルスケア・インフラへの投資、臨床試験のための共同研究などが挙げられます。現在のビジネスチャンスは、規制への適応性、デジタルヘルスプラットフォームとの統合、新興国への進出などにあります。しかし、遺伝子検査費用の高騰、複雑な規制状況、データプライバシーへの懸念、専門スキルの必要性などが市場成長の制約となっています。データ解析のための人工知能の革新、費用対効果の高いゲノム・ソリューションの開発、精度を高めるためのマルチオミクス・データの統合は、事業拡大の有望な手段です。さらに、利害関係者の認識を高め、信頼を醸成するための包括的な教育イニシアティブは、市場導入を大幅に促進することができます。また、バイオテクノロジー開発と臨床応用のギャップを埋めるための学際的コラボレーションも、ビジネスの成長を後押しします。プレシジョン・カーディオロジー市場は本質的にダイナミックであり、急速な技術進歩と進化する患者ケアのパラダイムによって定義されます。成功するためには、企業は技術開発に投資し、統合ケアモデルに焦点を当てた戦略的パートナーシップを形成する必要があります。そうすることで、市場のプレーヤーはプレシジョン・カーディオロジーの変革の可能性を活用できるだけでなく、患者の転帰を向上させ、ヘルスケアの持続可能性を促進するイノベーションを推進することができます。

市場力学：急速に進化するプレシジョン・カーディオロジー市場の主要市場インサイトを公開

プレシジョン・カーディオロジー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の有病率の増加
  • 世界の早期疾患スクリーニングの重視の高まり
• 市場抑制要因
  • プレシジョン・カーディオロジーに関連する高コスト
• 市場機会
  • プレシジョン・カーディオロジー検査の技術的進歩
  • 政府や企業による研究開発投資の増加
• 市場の課題
  • 規制機関による厳しい基準や規制

ポーターのファイブフォース：プレシジョン・カーディオロジー市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：プレシジョン・カーディオロジー市場における外部からの影響の把握

外部マクロ環境要因は、プレシジョン・カーディオロジー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析プレシジョン・カーディオロジー市場における競合情勢の把握

プレシジョン・カーディオロジー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスプレシジョン・カーディオロジー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、プレシジョン・カーディオロジー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨プレシジョン・カーディオロジー市場における成功への道筋を描く

プレシジョン・カーディオロジー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の罹患率の増加
    • 世界的に疾病の早期スクリーニングの重要性が高まっている
  • 抑制要因
    • プレシジョン・カーディオロジーに関連する高コスト
  • 機会
    • プレシジョン・カーディオロジーテストにおける技術的進歩
    • 政府と企業による研究開発への投資の増加
  • 課題
    • 規制機関によって定められた厳格な基準と規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 プレシジョン・カーディオロジー市場：提供別

• 製品
• サービス

第7章 プレシジョン・カーディオロジー市場サンプル

• 血
• 唾液

第8章 プレシジョン・カーディオロジー市場：技術別

• マイクロアレイ
• 次世代シーケンシング
• ポリメラーゼ連鎖反応

第9章 プレシジョン・カーディオロジー市場適応症別

• 大動脈症および血管疾患
• 不整脈
• 心筋症
• 先天性心疾患および症候群
• 家族性高コレステロール血症

第10章 プレシジョン・カーディオロジー市場：エンドユーザー別

• 学術調査機関
• 病院および診断研究所

第11章 南北アメリカのプレシジョン・カーディオロジー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のプレシジョン・カーディオロジー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのプレシジョン・カーディオロジー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ARUP Laboratories
• Centogene B.V.
• DNA Genotek Inc. by OraSure Technologies, Inc.
• Eurofins Scientific
• Exact Sciences Corporation
• Fulgent Genetics, Inc.
• GE HealthCare Technologies Inc.
• Genincode PLC
• IDOVEN 1903, S.L.
• Illumina, Inc.
• Invitae Corporation
• OPKO Health, Inc.
• PerkinElmer Genomics
• Quest Diagnostics Incorporated
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. PRECISION CARDIOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. PRECISION CARDIOLOGY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PRECISION CARDIOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PRECISION CARDIOLOGY MARKET DYNAMICS
• TABLE 7. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY AORTOPATHY AND VASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CARDIOMYOPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY CONGENITAL HEART DEFECTS & SYNDROMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY FAMILIAL HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PRECISION CARDIOLOGY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES PRECISION CARDIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 161. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 181. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM PRECISION CARDIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. PRECISION CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. PRECISION CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

The Precision Cardiology Market was valued at USD 13.84 billion in 2023, expected to reach USD 15.67 billion in 2024, and is projected to grow at a CAGR of 12.04%, to USD 30.68 billion by 2030.

Precision cardiology focuses on the tailored management of cardiovascular diseases (CVDs) by profiling patients' genetic, phenotypic, and lifestyle factors for targeted treatments. The necessity of precision cardiology arises from the rising global burden of CVDs, the leading cause of mortality worldwide, necessitating more personalized and effective treatment strategies. Applications span risk assessment, diagnostics, therapeutic monitoring, and medication personalization, providing significant end-use potential in clinical settings, research institutions, healthcare organizations, and biopharmaceutical companies. Market growth is predominantly driven by advancements in genomics and biotechnology, increasing adoption of personalized medicine, and heightened awareness of precision health benefits among clinicians and patients. Key growth enablers include government initiatives in genomics, investments in healthcare infrastructure, and collaborations for clinical trials. Current opportunities exist in regulatory adaptability, integration with digital health platforms, and expansion into emerging economies. However, market growth is constrained by high costs of genetic testing, complex regulatory landscapes, data privacy concerns, and the need for specialized skills. Innovation in artificial intelligence for data analysis, development of cost-effective genomic solutions, and integration of multi-omics data to enhance precision are promising avenues for business expansion. Moreover, comprehensive educational initiatives to increase stakeholder awareness and foster trust can substantially catalyze market adoption. Business growth can also be supported by interdisciplinary collaborations to bridge gaps between biotechnology developments and clinical applications. The precision cardiology market is inherently dynamic, defined by rapid technological advancements and evolving patient care paradigms. To succeed, companies should invest in technology development and form strategic partnerships focused on integrated care models, while also navigating the regulatory and ethical challenges inherent to the sector. By doing so, market players can not only capitalize on precision cardiology's transformative potential but also drive innovation that enhances patient outcomes and facilitates healthcare sustainability.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Precision Cardiology Market

The Precision Cardiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular diseases
  • Growing emphasis on early disease screening globally
• Market Restraints
  • High cost associated with precision cardiology
• Market Opportunities
  • Technological advancements in precision cardiology tests
  • Rise in investment in research and development by governments and businesses
• Market Challenges
  • Stringent standards and regulations laid by regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Precision Cardiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Precision Cardiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Precision Cardiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Precision Cardiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Precision Cardiology Market

A detailed market share analysis in the Precision Cardiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Precision Cardiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Precision Cardiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Precision Cardiology Market

A strategic analysis of the Precision Cardiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Precision Cardiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ARUP Laboratories, Centogene B.V., DNA Genotek Inc. by OraSure Technologies, Inc., Eurofins Scientific, Exact Sciences Corporation, Fulgent Genetics, Inc., GE HealthCare Technologies Inc., Genincode PLC, IDOVEN 1903, S.L., Illumina, Inc., Invitae Corporation, OPKO Health, Inc., PerkinElmer Genomics, Quest Diagnostics Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Precision Cardiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Product and Service.
• Based on Sample, market is studied across Blood and Saliva.
• Based on Technology, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
• Based on Indication, market is studied across Aortopathy and Vascular Diseases, Arrhythmia, Cardiomyopathy, Congenital Heart Defects & Syndromes, and Familial Hypercholesterolemia.
• Based on End-User, market is studied across Academic & Research Institutes and Hospitals & Diagnostic Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular diseases
    • 5.1.1.2. Growing emphasis on early disease screening globally
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with precision cardiology
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in precision cardiology tests
    • 5.1.3.2. Rise in investment in research and development by governments and businesses
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent standards and regulations laid by regulatory bodies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Precision Cardiology Market, by Offering

• 6.1. Introduction
• 6.2. Product
• 6.3. Service

7. Precision Cardiology Market, by Sample

• 7.1. Introduction
• 7.2. Blood
• 7.3. Saliva

8. Precision Cardiology Market, by Technology

• 8.1. Introduction
• 8.2. Microarray
• 8.3. Next-Generation Sequencing
• 8.4. Polymerase Chain Reaction

9. Precision Cardiology Market, by Indication

• 9.1. Introduction
• 9.2. Aortopathy and Vascular Diseases
• 9.3. Arrhythmia
• 9.4. Cardiomyopathy
• 9.5. Congenital Heart Defects & Syndromes
• 9.6. Familial Hypercholesterolemia

10. Precision Cardiology Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Hospitals & Diagnostic Laboratories

11. Americas Precision Cardiology Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Precision Cardiology Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Precision Cardiology Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ARUP Laboratories
• 3. Centogene B.V.
• 4. DNA Genotek Inc. by OraSure Technologies, Inc.
• 5. Eurofins Scientific
• 6. Exact Sciences Corporation
• 7. Fulgent Genetics, Inc.
• 8. GE HealthCare Technologies Inc.
• 9. Genincode PLC
• 10. IDOVEN 1903, S.L.
• 11. Illumina, Inc.
• 12. Invitae Corporation
• 13. OPKO Health, Inc.
• 14. PerkinElmer Genomics
• 15. Quest Diagnostics Incorporated
• 16. Thermo Fisher Scientific Inc.